Effect of Cooling Cap on Controlling Alopecia for Women Undergoing Chemotherapy

Naglaa Mohammed Amein Ghanem, Fatma Mostafa mahrous, Jackleen Fheem Gendy, Heba Abdel-Azem Mostafa
{"title":"Effect of Cooling Cap on Controlling Alopecia for Women Undergoing Chemotherapy","authors":"Naglaa Mohammed Amein Ghanem, Fatma Mostafa mahrous, Jackleen Fheem Gendy, Heba Abdel-Azem Mostafa","doi":"10.21608/ejhc.2023.329981","DOIUrl":null,"url":null,"abstract":"Background: Alopecia is an unpleasant side effect of chemotherapy that, on occasion, might cause patients to refuse treatment. The use of a cooling cap can help prevent chemotherapy-related alopecia. The aim of the study: is to determine the effect of cooling cap on controlling alopecia for women undergoing chemotherapy. Materials and methods: The study design used was a quasi-experimental research design. A purposive sample of 60 adult female patients, at the Oncology Center and Oncology clinic in Minia University age, ranged from 21 to 60 years old, with cancer and scheduled to be treated with adjuvant chemotherapy for the first time after curative surgery who met the inclusion criteria will be divided randomly 30 subjects in study group and 30 subjects in the control group, the study group were received cooling cap while they receiving their chemotherapy cycle while the control group received the routine hospital care. 2 tools used to include structure interview questionnaire and physiologic measurement tool for hair loss. The results of this study: There were 43.3% &3.3% have grade 4 (total alopecia) from the control and study group (CCG) respectively after the six cycles of chemotherapy. There is a highly significant difference between the two groups regarding grades of hair loss and there is good hair preservation by 86.7% in the study group (cooling cap group (CCG)) compared to 16.7% in the control group where P=0.000. Conclusion: The cooling cap is effective in the prevention of chemotherapy-induced alopecia in cancer patients. Recommendation: The cooling cap is effective and should be applied for cancer patients during chemotherapy cycles thus the cooling cap system should be available in governmental hospitals and the women with cancer who take adjuvant chemotherapy should be encouraged to use cooling cap to reduce total alopecia. Further psychological, clinical, and biological research is needed to improve the effect, tolerance, time, and side effects of the cooling procedure.","PeriodicalId":311996,"journal":{"name":"Egyptian Journal of Health Care","volume":"290 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Health Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ejhc.2023.329981","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Alopecia is an unpleasant side effect of chemotherapy that, on occasion, might cause patients to refuse treatment. The use of a cooling cap can help prevent chemotherapy-related alopecia. The aim of the study: is to determine the effect of cooling cap on controlling alopecia for women undergoing chemotherapy. Materials and methods: The study design used was a quasi-experimental research design. A purposive sample of 60 adult female patients, at the Oncology Center and Oncology clinic in Minia University age, ranged from 21 to 60 years old, with cancer and scheduled to be treated with adjuvant chemotherapy for the first time after curative surgery who met the inclusion criteria will be divided randomly 30 subjects in study group and 30 subjects in the control group, the study group were received cooling cap while they receiving their chemotherapy cycle while the control group received the routine hospital care. 2 tools used to include structure interview questionnaire and physiologic measurement tool for hair loss. The results of this study: There were 43.3% &3.3% have grade 4 (total alopecia) from the control and study group (CCG) respectively after the six cycles of chemotherapy. There is a highly significant difference between the two groups regarding grades of hair loss and there is good hair preservation by 86.7% in the study group (cooling cap group (CCG)) compared to 16.7% in the control group where P=0.000. Conclusion: The cooling cap is effective in the prevention of chemotherapy-induced alopecia in cancer patients. Recommendation: The cooling cap is effective and should be applied for cancer patients during chemotherapy cycles thus the cooling cap system should be available in governmental hospitals and the women with cancer who take adjuvant chemotherapy should be encouraged to use cooling cap to reduce total alopecia. Further psychological, clinical, and biological research is needed to improve the effect, tolerance, time, and side effects of the cooling procedure.
冷却帽对控制接受化疗妇女脱发的影响
背景:脱发是化疗的一种令人不快的副作用,有时可能导致患者拒绝接受治疗。使用降温帽有助于预防与化疗相关的脱发。研究目的:确定凉帽对控制接受化疗的女性脱发的效果。材料和方法:研究设计采用准实验研究设计。研究对象为米尼亚大学肿瘤中心和肿瘤诊所的 60 名成年女性患者,年龄从 21 岁到 60 岁不等,均为癌症患者,并计划在治愈性手术后首次接受辅助化疗,符合纳入标准的患者将被随机分为研究组 30 人和对照组 30 人,研究组在接受化疗的同时接受降温帽治疗,而对照组则接受医院的常规护理。使用的2种工具包括结构访谈问卷和脱发生理测量工具。研究结果在六个化疗周期后,对照组和研究组(CCG)中分别有 43.3% 和 3.3% 的患者出现四级脱发(完全脱发)。两组患者的脱发等级差异非常明显,研究组(冷却帽组(CCG))86.7%的患者头发保存良好,而对照组仅为 16.7%,P=0.000。结论降温帽能有效预防癌症患者化疗引起的脱发。建议:降温帽是有效的,应在癌症患者化疗期间使用,因此政府医院应配备降温帽系统,并鼓励接受辅助化疗的女性癌症患者使用降温帽,以减少总脱发。还需要进一步开展心理、临床和生物学研究,以改善冷却过程的效果、耐受性、时间和副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信